Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction
Myeloid RNA regulator of Bim-induced death ( Morrbid ) is a newly identified leukocyte-specific long noncoding RNA (lncRNA). However, the expression and biological functions of Morrbid in cardiomyocytes and heart disease are currently unclear. This study was meant to determine the role of cardiac Mo...
Gespeichert in:
Veröffentlicht in: | JCI insight 2023-08, Vol.8 (16) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Myeloid RNA regulator of Bim-induced death (
Morrbid
) is a newly identified leukocyte-specific long noncoding RNA (lncRNA). However, the expression and biological functions of
Morrbid
in cardiomyocytes and heart disease are currently unclear. This study was meant to determine the role of cardiac
Morrbid
in acute myocardial infarction (AMI) and to identify the potential cellular and molecular mechanisms involved. We found that both human and mouse cardiomyocytes could express a significant amount of
Morrbid
and that its expression was increased in cardiomyocytes with hypoxia or oxidative stress as well as in mouse hearts with AMI. Overexpression of
Morrbid
reduced the myocardial infarct size and cardiac dysfunction, whereas the infarct size and cardiac dysfunction deteriorated in cardiomyocyte-specific
Morrbid
-KO (
Morrbid
fl/fl
/Myh6-Cre) mice. We identified that
Morrbid
had a protective effect against hypoxia- or H
2
O
2
-induced apoptosis; this was also confirmed in vivo in mouse hearts after AMI. We further discovered that serpine1 was a direct target gene of
Morrbid
that was involved in the
Morrbid
-mediated protective effect on cardiomyocytes. In summary, we have found, for the first time to our knowledge, that the cardiac
Morrbid
is a stress-enhanced lncRNA that protects hearts from AMI via antiapoptosis through its target gene serpine1.
Morrbid
may be a novel promising therapeutic target for ischemic heart diseases such as AMI. |
---|---|
ISSN: | 2379-3708 2379-3708 |
DOI: | 10.1172/jci.insight.165568 |